Amgen Argues For Denial Of Sandoz’s High Court Review Of Patent Case
WASHINGTON, D.C. — Amgen Inc. and Amgen Manufacturing Limited (Amgen, collectively) on March 21 asked the U.S. Supreme Court to deny a request by Sandoz Inc. to review whether an appellate...To view the full article, register now.
Already a subscriber? Click here to view full article